New Insights on ASV in Sleep Medicine

In this episode of Talking Sleep, Dr. Douglas Bradley discusses the evolving landscape of sleep medicine amidst recent disruptions like COVID-19 and the Philips Respironics recall. These aren’t the first upheavals in the field—nearly a decade ago, the SERVE-HF study and the subsequent ResMed ASV device safety notice shook the industry.

Dr. Bradley shares the latest insights from a newly published trial that used Philips ASV devices, offering valuable findings on the use of peak-flow-triggered ASV in patients with an ejection fraction of 45% or below. Tune in to understand how these results could shape the future of sleep therapy.

Talking Sleep is brought to you by the American Academy of Sleep Medicine (AASM) and is available on the AASM YouTube channels. Subscribe for more expert discussions on advancements in sleep medicine.